Active, Not Recruiting
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
NCT05600777
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- GSK Investigational Site Foley, Alabama, United States
- GSK Investigational Site Litchfield Park, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States